Current status of molecularly targeted drugs for the treatment of advanced thyroid cancer

被引：5
|
作者：
Takami, Hiroshi E. [1 ]
机构：
[1] Teikyo Univ, Sch Med, Dept Surg, Itabashi Ku, Tokyo 1738605, Japan
来源：
ENDOCRINE JOURNAL | 2011年 / 58卷 / 03期
关键词：
Molecularly targeted drugs; Kinase inhibitors; Differentiated thyroid carcinoma; Medullary thyroid carcinoma; PHASE-II TRIAL; SORAFENIB; CARCINOMA;
D O I：
10.1507/endocrj.K11E-076
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The prognosis of almost all thyroid cancers is good, but some patients have indications for these molecularly targeted. drugs. Some of these drugs, i.e., vandetanib, XL-184, sorafenib, motesanib, axitinib, and pazopanib, are clearly useful clinically.
引用
收藏
页码：151 / 153
页数：3
相关论文
共 50 条
  • [31] Molecularly targeted therapy for advanced gastrointestinal noncolorectal cancer treatment: how to choose? Past, present, future
    Nigro, Olga
    Chini, Claudio
    Proserpio, Ilaria
    ANTI-CANCER DRUGS, 2021, 32 (06) : 593 - 601
  • [32] Molecularly targeted therapies in radioiodine refractory thyroid cancer-update 2022
    Koehler, Viktoria F.
    Westphalen, C. Benedikt
    Nagarajah, James
    Zacherl, Mathias
    Spitzweg, Christine
    ONKOLOGIE, 2022, 28 (08): : 649 - 659
  • [33] Targeted Therapies for Gastric Cancer Current Status
    Yoong, Jaclyn
    Michael, Michael
    Leong, Trevor
    DRUGS, 2011, 71 (11) : 1367 - 1384
  • [34] Current treatment in advanced renal cell carcinoma (RCC): Impact of targeted therapies in the management of RCC
    Bellmunt, Joaquim
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (07) : 484 - 491
  • [35] Treatment of advanced medullary thyroid cancer
    Smit J.
    Thyroid Research, 6 (Suppl 1)
  • [36] Prospects of Molecularly-Targeted Therapies for Cervical Cancer Treatment
    de Freitas, Antonio Carlos
    Gomes Leitao, Maria da Conceicao
    Coimbra, Eliane Campos
    CURRENT DRUG TARGETS, 2015, 16 (01) : 77 - 91
  • [37] Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond
    Cabanillas, Maria E.
    Ryder, Mabel
    Jimenez, Camilo
    ENDOCRINE REVIEWS, 2019, 40 (06) : 1573 - 1604
  • [38] A Decade of Progress in Targeted Therapy for Advanced Thyroid Cancer: An Overview
    Cabanillas, Maria E.
    Iyer, Priyanka C.
    Hu, Mimi I.
    ENDOCRINE PRACTICE, 2023, 29 (03) : 221 - 227
  • [39] Current Bioanalysis of Molecularly Targeted Drugs Using Liquid Chromatography-Tandem Mass Spectrometry
    Hirayama, Chiho
    Kuno, Ayana
    Furusho, Aogu
    Sugiyama, Eiji
    Todoroki, Kenichiro
    CHROMATOGRAPHY, 2023, 44 (02) : 45 - 54
  • [40] An update on clinical trials of targeted therapies in thyroid cancer
    Haraldsdottir, Sigurdis
    Shah, Manisha H.
    CURRENT OPINION IN ONCOLOGY, 2014, 26 (01) : 36 - 44
12345